Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight FDA OFFICE OF ACQ GRANT SVCS (75F401) is its largest buyer. See more on the Buyers tab
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $35.9K in FY2021. See more on the Contracts tab
Click a state to open its page.
Insight 100% was performed in Maryland. See more on the Contracts tab
Contracts
12 contracts with an action since FY2021
Click a tile to open its contract.
Insight 75F40120D00023 orders hold 100% of these contracts' obligations.
Hover over a year to see its value.
Insight 93% of its prime obligations came through 75F40120D00023 orders.
Bafs Inc. prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
0 end within 12 months.
Showing 1–10 of 12 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| 75F40123F19010 | 75F40120D00023 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $14,160 | Apr 1, 2023 | Ended |
| 75F40121F19003 | 75F40120D00023 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $12,982 | Jul 30, 2021 | Ended |
| 75F40121F19004 | 75F40120D00023 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $12,385 | Aug 1, 2021 | Ended |
| 75F40121F19002 | 75F40120D00023 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $10,520 | Jan 18, 2021 | Ended |
| 75F40123F19011 | 75F40120D00023 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $8,895 | Feb 28, 2023 | Ended |
| 75F40123F19009 | 75F40120D00023 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $7,263 | Jan 31, 2023 | Ended |
| 75F40124F19014 | 75F40120D00023 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $7,125 | Aug 31, 2024 | Ended |
| 75F40125F19015 | 75F40120D00023 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $3,214 | Feb 28, 2025 | Ended |
| 75F40124F19013 | 75F40120D00023 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $3,168 | May 31, 2024 | Ended |
| 75F40122F19008 | 75F40120D00023 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $2,511 | Aug 31, 2022 | Ended |
Buyers
Food and Drug Administration: $86.3K obligated since award; $86.4K in FY2021–FY2025 actions
Click a bar to open its office page.
Insight Food and Drug Administration placed 100%.
Contracting offices that awarded Bafs Inc. prime contracts, FY2021–FY2026
See which offices award its contracts.
0 offices awarded only one contract.
Showing 1–1 of 1 office
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| FDA OFFICE OF ACQ GRANT SVCS (75F401) | Food and Drug Administration | 12 | $86,324 | Dec 9, 2020 | Feb 10, 2026 |
Opportunities
Open opportunities matching Bafs Inc.'s registered industries
Notices in its 2 industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 444240, 459910
No open notice matches these industries today. New notices arrive every day.
Registration and contacts
Registration
- UEI
- GC5UMAJU1JK9
- CAGE code
- 81Z50
- Registration
- Active, expires Mar 4, 2027
- Entity type
- Corporate Entity (Not Tax Exempt)
- Location
- BEL AIR, MD, 21014
- Congressional district
- MD-01
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 2 industries; primary 444240
Contacts at Bafs Inc.
| Contact | Role | As of |
|---|---|---|
| No public contact on file | ||
Correct this listing
Tell us what to correct or add on the Bafs Inc. page. We check every request before we change a profile.